Home NDTV News - Topstories Bharat Biotech's Covaxin Approval Requested In US For Children Below 18

Bharat Biotech's Covaxin Approval Requested In US For Children Below 18

November 05, 2021

A+ A- Print Email

https://ift.tt/eA8V8J
https://www.ndtv.com
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

from NDTV News - Topstories https://ift.tt/3bIUCMT
via IFTTT

Labels: NDTV News - Topstories

Post a Comment

Subscribe to: Post Comments (Atom)